← 產業報告目錄
Transthyretin Amyloidosis Treatment Market Size, Share & Trends Analysis Report By Type (ATTR-PN, ATTR-CM), By Therapy (Targeted Therapy (Onpattro, Inotersen, Vyndaqel/Vyndamax), Supportive Therapy, Pipeline Therapy), By Disease Type (Hereditary Transthyretin Amyloidosis (Polyneuropathy, Cardiomyopathy, Mixed Type), Wild Type Amyloidosis), By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-02頁數 165報告編號 INSIGHTACE-dc4aa1a4a1
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 5.5 Bn, the global Transthyretin Amyloidosis Treatment Market is projected to expand to USD 11.7 Bn by 2034, demonstrating a CAGR of 8.0% during the 2025–2034 forecast window.
At its core, Transthyretin Amyloidosis Treatment pertains to an uncommon and progressive condition resulting from the misfolding of transthyretin (ttr) proteins, which leads to amyloid accumulation in organs and tissues, most. Stakeholders across the healthcare landscape are growingly turning to these solutions to meet contemporary demands.
Market momentum is bolstered by growing requirement advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Transthyretin Amyloidosis Treatment Market Snapshot
Chapter 4. Global Transthyretin Amyloidosis Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2021-2034
4.8. Global Transthyretin Amyloidosis Treatment Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on Transthyretin Amyloidosis Treatment Industry Trends
Chapter 5. Transthyretin Amyloidosis Treatment Market Segmentation 1: By Therapy, Estimates & Trend Analysis
5.1. Market Share by Therapy, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Therapy:
5.2.1. Targeted Therapy
5.2.1.1. Onpattro
5.2.1.2. Inotersen
5.2.1.3. Vyndaqel/Vyndamax
5.2.2. Supportive Therapy
5.2.3. Pipeline Therapy
Chapter 6. Transthyretin Amyloidosis Treatment Market Segmentation 2: By Type, Estimates & Trend Analysis
6.1. Market Share by Type, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Types:
6.2.1. ATTR-PN
6.2.2. ATTR-CM
Chapter 7. Transthyretin Amyloidosis Treatment Market Segmentation 3: By Disease Type, Estimates & Trend Analysis
7.1. Market Share by Disease Type, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Disease Types:
7.2.1. Hereditary Transthyretin Amyloidosis
7.2.1.1. Polyneuropathy
7.2.1.2. Cardiomyopathy
7.2.1.3. Mixed Type
7.2.2. Wild Type Amyloidosis
Chapter 8. Transthyretin Amyloidosis Treatment Market Segmentation 4: By Distribution Channel Industry, Estimates & Trend Analysis
8.1. Market Share by Distribution Channel Industry, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel Industrys:
8.2.1. Hospital Pharmacies
8.2.2. Specialty Pharmacies
8.2.3. Retail Pharmacies
8.2.4. Online Pharmacies
Chapter 9. Transthyretin Amyloidosis Treatment Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Transthyretin Amyloidosis Treatment Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
9.2.3. North America Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.2.4. North America Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2021-2034
9.2.5. North America Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel Industry, 2021-2034
9.3. Europe
9.3.1. Europe Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
9.3.3. Europe Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.3.4. Europe Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2021-2034
9.3.5. Europe Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel Industry, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
9.4.3. Asia Pacific Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.4.4. Asia Pacific Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts By Disease Type, 2021-2034
9.4.5. Asia Pacific Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel Industry, 2021-2034
9.5. Latin America
9.5.1. Latin America Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
9.5.3. Latin America Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.5.4. Latin America Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2021-2034
9.5.5. Latin America Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel Industry, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Therapy, 2021-2034
9.6.3. Middle East & Africa Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.6.4. Middle East & Africa Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2021-2034
9.6.5. Middle East & Africa Transthyretin Amyloidosis Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel Industry, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Pfizer Inc.
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Offerings
10.2.1.3. Financial PerTherapyance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Johnson & Johnson Services, Inc.
10.2.3. Ionis Pharmaceuticals, Inc.
10.2.4. Alnylam Pharmaceuticals, Inc.
10.2.5. BridgeBio Pharma, Inc.
10.2.6. Bristol-Myers Squibb Company
10.2.7. Acrotech Biopharma
10.2.8. AstraZeneca
10.2.9. Astellas Pharma, Inc.
10.2.10. Prothena
10.2.11. SOM Biotech
10.2.12. Other Market Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們